LabMedica

Download Mobile App
Recent News Expo ADLM 2025 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Agilent Technologies Acquires Dako to Expand Diagnostic Solutions Portfolio

By LabMedica International staff writers
Posted on 18 May 2012
Agilent Technologies Inc. (Agilent; Santa Clara, CA, USA), a bio-analytical technology solutions company, has announced an agreement to acquire Dako (Glostrup, Denmark), a global, tissue-based cancer diagnostic company, from the private equity group EQT (Sweden) for USD 2.2 billion in order to strengthen Agilent’s product line and offer patients and healthcare professionals improved cancer diagnostic tools and services.

Agilent's bio-analytical measurement business provides instruments, software, and services for the purpose of identifying and analyzing the physical and biological properties of substances and products. Similarly, Dako provides antibodies, reagents, scientific instruments, and software primarily to customers in pathology laboratories for faster and improved diagnostics for cancer patients. The acquisition aims to improve both companies’ services to create innovative medical and diagnostic solutions.

According to Bill Sullivan, president and CEO, Agilent, the partnership with Dako, which he describes as “one of the world's leading providers of cancer diagnostics tools,” will help create a broader range of solutions to fight cancer and improve patient care.

"Agilent's strategy in acquiring Dako is about strengthening the company's presence in life science and about revenue growth," added Mr. Sullivan. "Dako employs extremely talented people with specialized expertise that we highly value. Their knowledge and experience will be very important as we move forward together."

Lars Holmkvist, CEO, Dako, agrees that the acquisition will help advance each company’s technologies to provide improved diagnostics products.

"Our combined companies will have complementary strengths. Like Agilent, Dako has a long history as a leader in scientific advancement and a culture that values discovery and innovation. We believe that Agilent and Dako are a winning combination," added Mr. Holmkvist.


Related Links:

Agilent Technologies Inc.

Dako

EQT







New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Serological Pipet Controller
PIPETBOY GENIUS
New
Gold Member
Automated Cell Culture Chemistry Analyzer
BioProfile FLEX2 Basic
New
Silver Member
Quality Control Material
Multichem ID-B

Latest Industry News

Quanterix Completes Acquisition of Akoya Biosciences
18 May 2012  |   Industry

Lunit and Microsoft Collaborate to Advance AI-Driven Cancer Diagnosis
18 May 2012  |   Industry

AMP Releases Best Practice Recommendations to Guide Clinical Laboratories Offering HRD Testing
18 May 2012  |   Industry



PURITAN MEDICAL